Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus

Journal of Diabetes and its Complications

Volumn 10, Issue 4, 1996, Pages 211-219

  Nguyen, Hung T ^a   Luzio, Stephen D ^b   Dolben, John ^b   West, James ^c   Beck, Lyn ^c   Coates, Philip A ^b   Owens, David R ^b  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; UREA;

ADULT; AGED; ARTICLE; BODY MASS; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINA MACULOPATHY; RISK FACTOR; UREA BLOOD LEVEL;

EID: 0030575319     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)00059-3     Document Type: Article

References (42)

1. 1. Ballard DJ, Melton LJ, Dwyer MS, Trautmann JC, Chu CP, O'Fallon WM, Palumbo PJ: Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care 9:334-342, 1986.
2. 2. Burns-Cox CJ, Grey RHB, Hughes A: Diabetes as a cause of blindness in Avon. Diabetic Med 5(suppl):3, 1988.
3. 3. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819, 1992.
4. 4. Fairchild JM, Hing SJ, Donaghue KC, Bonney MA, Fung ATW, Stephens MM, Mitchell P, Howard NJ, Silink M: Prevalence and risk factors for diabetic retinopathy in adolescents with type 1 diabetes. Med J Aust 160:757-761, 1994.
5. 5. Davis MD: Diabetic retinopathy. Diabetes Care 15:1844-1874, 1992.
6. 6. Klein R, Moss SE, Klein BEK, David MD, DeMets DL: Wisconsin epidemiologic study of diabetic retinopathy: XII. Relationship of C-peptide and diabetic retinopathy. Diabetes 39:1445-1450, 1990.
7. 7. Monson JP, Koios G, Toms GC, Kopelman PG, Boucher BJ, Evans SJW, Alexander WL: Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes. J R Soc Med 79: 274-276, 1986.
8. 8. Nathan DM, Singer DE, Godin JE, Harrington CH, Perlmutr LC: Retinopathy in older type II diabetics: Association with glucose control. Diabetes 35:797-801, 1986.
9. 9. Turkington RW, Weindling HK: Insulin secretion in the diagnosis of adult-onset diabetes mellitus. JAMA 240: 833-836, 1978.
10. 10. Sjo»berg S, Gunnarsson R, Gjo»tterberg M, Lefvert AK, Persson A, Ostman J: Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:208-213, 1987.
11. 11. Jarrett RJ: Duration of non-insulin-dependent diabetes and development of retinopathy. Diabetic Med 3:261-263, 1986.
12. 12. Barnett AH, Britton JR, Leatherdale BA: Study of possible risk factors for severe retinopathy in non-insulin dependent diabetes. BMJ 287:529, 1983.
13. 13. Raskin P: Risk factors for the development of diabetic complications. J Diabet Complications 8:195-200, 1994.
14. 14. Alzaid AA, Dinneen SF, Melton III LJ, Rizza RA: The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 17:531-534, 1994.
15. 15. Barnes AJ, Kohner EM, Johnston DG, Alberti KGMM: Severe retinopathy and mild carbohydrate intolerance: Possible role of insulin deficiency and elevated circulating growth hormone. Lancet i:1465-1468, 1985.
16. 16. Heding LG: Determination of total serum insulin (IRI) in insulin treated diabetic patients. Diabetologia 8:260-266, 1972.
17. 17. Sieldel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW: Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19:838-839, 1981.
18. 18. Burnstein M, Scholnick HR, Morfin R: Rapid method for the isolation of lipoproteins for human serum by precipitation with polyanions. J Lipid Res 2:583-595, 1970.
19. 19. Wahlefeld AW: Triglycerides. Determination after enzymatic hydrolysis, in Bergmeyer HV(ed), Methods of Enzymatic Analysis. 2nd English edition. New York, Verlag Chemie Weinheim and Academic, 1974, p. 1831.
20. 20. Friedwald WT, Levy R, Fredrickson D: Estimation of the concentration of LDL cholesterol in plasma without the use of the preparation ultracentrifuge. Clin Chem 18:499-502, 1972.
21. 21. Boden G, Soeldner JS: A sensitive double antibody radioimmunoassay for human growth hormone (HGH): Levels of serum HGH following rapid tolbutamide infusion. Diabetologia 3:413-421, 1967.
22. 22. Klein R, Klein BEK, Moss SE: Diabetes, hyperglycaemia, and age-related maculopathy - The Beaver Dam eye study. Ophthalmology 99:1527-1534, 1992.
23. 23. Aldington SJ, Kohner EM, Nugent A: Retinopathy at entry in the United Kingdom prospective diabetes study (UKPDS) of maturity onset diabetes. Diabetic Med 4:355, 1987.
24. 24. Barnett AH, Dallinger K, Jennings P, Fletcher J, Odugbesan O: Microalbuminura and diabetic retinopathy. Lancet i:53-55, 1985.
25. 25. Dolben J, Owens DR, Young S, Vora J, Atiea J, Dean J, Luzio S: Retinopathy at presentation in type 2 (non-insulin dependent) diabetic patients. Diabetic Med 5(suppl 2):20, 1988.
26. 26. Dorf A, Ballintine EJ, Bennett PH, Miller M: Retinopathy in Pima Indians. Diabetes 25:554-560, 1976.
27. 27. Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, Van Heuven WAJ, Klein R: Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 37:878-884, 1988.
28. 28. Hamman RF, Mayer EJ, Moo-Yong GA, Hildebrandt W, Marshall JA, Baxter J: Prevalence and risk factors of diabetic retinopathy in non-Hispanic white and Hispanics with NIDDM. Diabetes 38:1231-1237, 1989.
29. 29. Hanis CL, Chu HH, Lawson K, Hewett-Emmett D, Barton SA, Schull WJ, Garcia CA: Mortality of Mexican and other predictors in Starr County, Texas. Diabetes Care 16: 82-89, 1993.
30. 30. Hattori N, Moridera K, Ishihara T, Hino M, Ikekubo K, Kurahachi H: Is growth hormone associated with diabetic retinopathy. J Diabet Complications 7:12-14, 1993.
31. 31. Howard-Williams J, Hillson RM, Bron A, Awdry P, Mann JI, Hockaday TDR: Retinopathy is associated with higher glycaemia in maturity-onset type diabetes. Diabetologia 27:198-202, 1984.
32. 32. Klein R, Klein BEK, Moss SE, Linton KL: The Beaver Dam eye study: Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1:58-62, 1992.
33. 33. Klein BEK, Moss SE, Klein R, Surawicz TS: Serum cholesterol in Wisconsin epidemiologic study of diabetic retinopathy. Diabetes Care 15:282-285, 1992.
34. 34. Klein R, Klein BEK, Moss SE: Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15:1875-1891, 1992.
35. 35. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ: Prevalence of diabetic complications in relation to risks factors. Diabetes 35:1332-1339, 1986.
36. 36. Moskalets E, Galstyan G, Starostina E, Antsiferov M, Chantelau E: Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabet Complications 8:45-50, 1994.
37. 37. Owens DR, Vølund A, Jones D, et al., Retinopathy in newly presenting non-insulin dependent (type 2) diabetic patients. Diabetes Res 9:59-65, 1989.
38. 38. Patrick W, Leslie PJ, Clark BF, Frier BM: The natural history and association of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 7:902-908, 1990.
39. 39. Santigo JV: Perspectives in diabetes: Lessons from the Diabetes Control and Complications Trial. Diabetes 42:1549-1558, 1993.
40. 40. Strowig S, Raskin P: Glycemic control and diabetic complications. Diabetes Care 15:1126-1140, 1992.
41. 41. Teuscher A, Schnell H, Wilson PWF: Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 11:246-251, 1988.
42. 42. West KM, Erdreich LJ, Stober JA: A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29:501-508, 1980.